ACTRN12611001200976招募中2 期
A Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and the Biological and Cognitive Effects of VEL015 (Sodium Selenate) in Patients with Mild to Moderate Alzheimer’s Disease – a Pilot Study
Velacor Therapeutics0 个研究点目标入组 40 人开始时间: 2011年11月22日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 55 Years 至 o limit（—）
- 性别
- All
入选标准
- •Modified Hachinski Ischaemia Score of 4 or less
- •MMSE between 12-26
- •Acetylcholine esterase inhibitor (AChEI) treatment on a stable dose for at least 4mths
- •Living in the community with access to a carer
排除标准
- •Treatment with memantine
- •Serious chronic uncontrolled disease other than Alzheimer's disease
- •Neurological illness that could contribute to non-Alzheimer's disease dementia
- •Familial history of Alzheimer's Disease
研究者
相似试验
进行中（未招募）
不适用
A Randomised, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Dutasteride (AVODART™) 0.5 mg in Extending the Time to PSA Doubling in Men with Prostate Cancer and Biochemical Failure (PSA increase) after Radical Therapy with Curative Intent (ARTS – AVODART after Radical Therapy for prostate cancer Study) - ARTSClinically localised prostate cancerMedDRA version: 9.1Level: LLTClassification code 10060862Term: Prostate cancerEUCTR2007-001703-38-DEGlaxoSmithKline Research and Development Ltd276
进行中（未招募）
不适用
A Randomised, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Dutasteride (AVODART™) 0.5 mg in Extending the Time to PSA Doubling in Men with Prostate Cancer and Biochemical Failure (PSA increase) after Radical Therapy with Curative Intent (ARTS – AVODART after Radical Therapy for prostate cancer Study)Clinically localised prostate cancerMedDRA version: 9.1Level: LLTClassification code 10060862Term: Prostate cancerEUCTR2007-001703-38-GBGlaxoSmithKline Research and Development Ltd276
已完成
3 期
A Randomised, Double-Blind, Placebo-Controlled Trial of the Effects of Selenium Supplementation on Pregnancy Outcome and Disease Progression in HIV-Infected Pregnant Women in Lagos, NigeriaPACTR201809756724274College of Medicine University of Lagos180
进行中（未招募）
1 期
A Randomised, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Diltiazem Hydrochloride Cream in Subjects with Anal Fissure - Diltiazem hydrochloride cream for anal fissure.Symptomatic relief of pain related to anal fissure (AF).MedDRA version: 12.1 Level: LLT Classification code 10002153 Term: Anal fissureEUCTR2008-005172-26-GBS.L.A. Pharma (UK) Ltd465
进行中（未招募）
不适用
A Randomised, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Dutasteride (AVODART™) 0.5 mg in Extending the Time to PSA Doubling in Men with Prostate Cancer and Biochemical Failure (PSA increase) after Radical Therapy with Curative Intent (ARTS – AVODART after Radical Therapy for prostate cancer Study)EUCTR2007-001703-38-EEGlaxoSmithKline Research and Development Ltd276